32 participants
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-05-05
- Start Date:
- 2013-12-31
- Completion:
- 2016-04-30
Conditions
- Indolent Non-Hodgkin's Lymphoma
Interventions
- BIOLOGICAL